# 0409-4911-34 · Atropine Sulfate Injection · Hospira, Inc., a Pfizer Company — FDA drug shortage duration tracker

For 0409-4911-34 · Atropine Sulfate Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-4911-34; generic name is Atropine Sulfate Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-10.

- **Package NDC:** 0409-4911-34 _(verified: appears in the quote below)_
- **Generic name:** Atropine Sulfate Injection _(verified: appears in the quote below)_
- **Manufacturer:** Hospira, Inc., a Pfizer Company _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Unavailable _(verified: appears in the quote below)_
- **FDA note:** Discontinuation of the manufacture of the drug _(verified: appears in the quote below)_
- **Initial posting date:** 01/01/2012 _(verified: appears in the quote below)_
- **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 5357 _(our reading, not quoted from the source)_
- **Reason for shortage:** Discontinuation of the manufacture of the drug _(verified: appears in its own passage below)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Anesthesia _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "01/01/2012", "package_ndc": "0409-4911-34", "generic_name": "Atropine Sulfate Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Atropine+Sulfate+Injection&st=d&tab=tabs-2", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Discontinuation of the manufacture of the drug"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Neurology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)\"", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"

### Status

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Neurology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)\"", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"

### Last update date

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Neurology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)\"", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"

### Reason for shortage

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Neurology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)\"", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"

### Dosage form

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Neurology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)\"", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"

### Therapeutic category

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Neurology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)\"", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-10. Review by: 2026-09-13.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).